cGMP Responsibilities for Own Label Distributors and Brand Owners
This webinar will help you understand how to meet the requirements of an Own Label Distributor and comply with FDA regulations.
Health Canada
Interested in doing business of health products in Canada? This free webinar provides an overview of the Canadian regulation on natural health products and how EAS can assist companies with the diverse requirements of Health Canada.
Shelly Blackwell interviewed for NutraIngredients USA
Shelly Blackwell, Senior Director for Dietary Supplement and Tobacco Consulting Services at EAS Consulting Group, provided timely and practical insights in her recent interview with NutraIngredients-USA. Speaking with Danielle Masterson at the RSQ Conference,...
Heads-up: Front-of-Pack labels, GRAS changes, and supplement definition update
Heads-up: Front-of-Pack labels, GRAS changes, and supplement definition update FDA has signaled three significant rulemakings in the Unified Agenda that could affect food and dietary supplement companies. These are not official final rules—but they’re far enough along...
FDA Encourages Food Manufacturers to Accelerate Phasing Out the Use of FD&C Red No. 3 in Foods Before 2027 Deadline
July 14, 2025 View on FDA Website On January 15, 2025, the U.S. Food and Drug Administration issued an orderrevoking the authorization for the use of FD&C Red No. 3 in foods, including dietary supplements (permitted under 21 Code of Federal Regulations (CFR)...
Dietary Component Specifications and Testing
Since the FDA’s dietary supplement cGMP regulations (21 CFR Part 111) were published, specifications and testing have been consistently one of the most frequently cited FDA observations. Specifically, industry continues to face challenges in complying with the specification and testing requirements for dietary supplement components.